The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Gene therapy progress and prospects: adenoviral vectors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Y., Chirmule, N., Gao, G.-P., Qian, R., Croyle, M., Joshi, B., Tazelaar, J., & Wilson, J. M. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0329 · Cited by 376
Mäkinen, K., Manninen, H., Hedman, M., Matsi, P., Mussalo, H., Alhava, E., & Ylä-Herttuala, S. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0638 · Cited by 374
Raper, S. E., Yudkoff, M., Chirmule, N., Gao, G.-P., Nunes, F., Haskal, Z. J., Furth, E. E., Propert, K. J., Robinson, M. B., Magosin, S., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712719 · Cited by 354
Schnell, M. A., Zhang, Y., Tazelaar, J., Gao, G.-P., Yu, Q. C., Qian, R., Chen, S.-J., Varnavski, A. N., LeClair, C., Raper, S. E., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0330 · Cited by 342
Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
Fisher, K., Stallwood, Y., Green, N., Ulbrich, K., Mautner, V, & Seymour, L. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301389 · Cited by 316
Dechecchi, M. C., Melotti, P., Bonizzato, A., Santacatterina, M., Chilosi, M., & Cabrini, G. (2001) · Journal of Virology · doi:10.1128/jvi.75.18.8772-8780.2001 · Cited by 291
Croyle, M. A., Chirmule, N., Zhang, Y., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.10.4792-4801.2001 · Cited by 229
Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-κB-Dependent Pathway
Morelli, A. E., Larregina, A. T., Ganster, R. W., Zahorchak, A. F., Plowey, J. M., Takayama, T., Logar, A. J., Robbins, P. D., Falo, L. D., & Thomson, A. W. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9617-9628.2000 · Cited by 222
Kim, I.-H., Józkowicz, A., Piedra, P. A., Oka, K., & Chan, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241506298 · Cited by 222
A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis
Bakker, A., Van de Loo, F., Joosten, L., Bennink, M., Arntz, O., Dmitriev, I., Kashentsera, E., Curiel, D., & van den Berg, W. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301612 · Cited by 213
Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease
Havenga, M. J. E., Lemckert, A. A. C., Ophorst, O. J. A. E., van Meijer, M., Germeraad, W. T. V., Grimbergen, J., van den Doel, M. A., Vogels, R., van Deutekom, J., Janson, A. A. M., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4612-4620.2002 · Cited by 192
Barnett, B. G., Crews, C. J., & Douglas, J. T. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00249-x · Cited by 174
(2002) · Human Gene Therapy · doi:10.1089/10430340152712629 · Cited by 174
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer
Buller, R. E., Runnebaum, I. B., Karlan, B. Y., Horowitz, J. A., Shahin, M., Buekers, T., Petrauskas, S., Kreienberg, R., Slamon, D., & Pegram, M. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700472 · Cited by 164
Morral, N., O'Neal, W. K., Rice, K., Leland, M. M., Piedra, P. A., Aguilar-Córdova, E., Carey, K. D., Beaudet, A. L., & Langston, C. (2002) · Human Gene Therapy · doi:10.1089/10430340152712692 · Cited by 163
Xia, H., Anderson, B., Mao, Q., & Davidson, B. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11359-11366.2000 · Cited by 162
Umaña, P., Gerdes, C. A., Stone, D., Davis, J. R., Ward, D., Castro, M. G., & Lowenstein, P. R. (2001) · Nature Biotechnology · doi:10.1038/89349 · Cited by 150
Borgland, S. L., Bowen, G. P., Wong, N. C. W., Libermann, T. A., & Muruve, D. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.3941-3947.2000 · Cited by 146
Genetic Targeting of Adenoviral Vectors
Krasnykh, V. N., Douglas, J. T., & van Beusechem, V. W. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0062 · Cited by 145
Nicklin, S. A., Seggern, D. J. V., Work, L. M., Pek, D. C. K., Dominiczak, A. F., Nemerow, G. R., & Baker, A. H. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0489 · Cited by 144
Ehrhardt, A., & Kay, M. A. (2002) · Blood · doi:10.1182/blood.v99.11.3923 · Cited by 141
High-Capacity “Gutless” Adenoviral Vectors
Schiedner, G., Clemens, P. R., Volpers, C., & Kochanek, S. (2002) · Elsevier eBooks · doi:10.1016/b978-012199504-1/50016-x · Cited by 137
Cheshenko, N., Krougliak, N., Eisensmith, R. C., & Krougliak, V. A. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301459 · Cited by 135
Harvey, B., Maroni, J. M., O'Donoghue, K. A., Chu, K. W., Muscat, J. C., Pippo, A. L., Wright, C. E., Hollmann, C., Wisnivesky, J. P., Kessler, P., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712638 · Cited by 132
Smith, T. A., Idamakanti, N., Kylefjord, H., Rollence, M. L., King, L., Kaloss, M., Kaleko, M., & Stevenson, S. C. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0613 · Cited by 130
Complement activation by recombinant adenoviruses
Cichon, G., Boeckh-Herwig, S., Schmidt, H., Wehnes, E., Müller, T. H., Pring‐Åkerblom, P., & Burger, R. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301611 · Cited by 128
Toxicity of a First-Generation Adenoviral Vector in Rhesus Macaques
Lozier, J. N., Csákó, G., Mondoro, T. H., Krizek, D. M., Metzger, M. E., Costello, R., Vostal, J. G., Rick, M. E., Donahue, R. E., & Morgan, R. A. (2002) · Human Gene Therapy · doi:10.1089/10430340152712665 · Cited by 128
Ligand-directed targeting of genes to the site of disease
Wickham, T. J. (2003) · Nature Medicine · doi:10.1038/nm0103-135 · Cited by 125
Reddy, P. S., Sakhuja, K., Ganesh, S., Yang, L., Kayda, D. B., Brann, T. W., Pattison, S. T., Golightly, D., Idamakanti, N., Pinkstaff, A., et al. (2002) · Molecular Therapy · doi:10.1006/mthe.2001.0510 · Cited by 123
Development of a FLP/frt System for Generating Helper-Dependent Adenoviral Vectors
Ng, P., Beauchamp, C., Evelegh, C. M., Parks, R. J., & Graham, F. L. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0323 · Cited by 122
Higginbotham, J. N., Seth, P. K., Blaese, R. M., & Ramsey, W. J. (2002) · Human Gene Therapy · doi:10.1089/10430340152712683 · Cited by 117
Nettelbeck, D. M., Miller, D. W., Jérôme, V., Zuzarte, M., Watkins, S. J., Hawkins, R. E., Müller, R., & Kontermann, R. E. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0342 · Cited by 115
Genetic Retargeting of Adenovirus: Novel Strategy Employing “Deknobbing” of the Fiber
Magnusson, M. K., Hong, S. S., Boulanger, P. A., & Lindholm, L. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7280-7289.2001 · Cited by 112
Bilamellar Cationic Liposomes Protect Adenovectors from Preexisting Humoral Immune Responses
Yotnda, P., Chen, D.-H., Chiu, W., Piedra, P. A., Davis, A. R., Templeton, N. S., & Brenner, M. K. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0545 · Cited by 111
Immune Evasion by Muscle-Specific Gene Expression in Dystrophic Muscle
Hartigan-O’Connor, D. J., Kirk, C. J., Crawford, R., Mulé, J. J., & Chamberlain, J. S. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0496 · Cited by 107
Gerdes, C. A., Castro, M. G., & Lowenstein, P. R. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0140 · Cited by 102
Moffatt, S., Hays, J. P., HogenEsch, H., & Mittal, S. K. (2000) · Virology · doi:10.1006/viro.2000.0350 · Cited by 100
Optimization of the Generation and Propagation of Gutless Adenoviral Vectors
Sakhuja, K., Reddy, P. S., Ganesh, S., Cantaniag, F., Pattison, S. T., Limbach, P., Kayda, D. B., Kadan, M. J., Kaleko, M., & Connelly, S. (2003) · Human Gene Therapy · doi:10.1089/10430340360535797 · Cited by 86
Molecular regulation and biological function of adenovirus early genes: the E4 ORFs
Täuber, B., & Dobner, T. (2001) · Gene · doi:10.1016/s0378-1119(01)00722-3 · Cited by 86
Recombinant adenovirus vectors with knobless fibers for targeted gene transfer
van Beusechem, V. W., van Rijswijk, A. L. C. T., van Es, H. H. G., Haisma, H. J., Pinedo, H. M., & Gerritsen, W. R. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301323 · Cited by 83
Crystal, R. G., Harvey, B., Wisnivesky, J. P., O'Donoghue, K. A., Chu, K. W., Maroni, J. M., Muscat, J. C., Pippo, A. L., Wright, C. E., Kaner, R. J., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712647 · Cited by 78
Andrews, J. L., Kadan, M. J., Gorziglia, M. I., Kaleko, M., & Connelly, S. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0264 · Cited by 66
Localized adenovirus gene delivery using antiviral IgG complexation
Levy, R. J., Song, C., Tallapragada, S., DeFelice, S., Hinson, J. T., Vyavahare, N. R., Connolly, J. D. R., Ryan, K., & Li, Q. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301452 · Cited by 65
Ding, E., Hodges, B. L., Hu, H., McVie-Wylie, A. J., Serra, D. M., Migone, F., Pressley, D., Chen, Y.-T., & Amalfitano, A. (2001) · Human Gene Therapy · doi:10.1089/104303401750195917 · Cited by 64
Targeting of High-Capacity Adenoviral Vectors
Biermann, V., Volpers, C., Hussmann, S., Stock, A., Kewes, H., Schiedner, G., Herrmann, A., & Kochanek, S. (2001) · Human Gene Therapy · doi:10.1089/104303401750476258 · Cited by 63
Induction of cell death by adenoviruses
Braithwaite, A. W., & Russell, I. A. (2001) · APOPTOSIS · doi:10.1023/a:1011338119712 · Cited by 60
Thummala, N. R., Ghosh, S. S., Lee, S. W., Reddy, B., Davidson, A., Horwitz, M. S., Chowdhury, J. R., & Chowdhury, N. R. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301729 · Cited by 58
Rahman, A., Tsai, V., Goudreau, A., Shinoda, J., Wen, S. F., Ramachandra, M., Ralston, R., Maneval, D. C., LaFace, D., & Shabram, P. W. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0316 · Cited by 50
Zhou, H., & Beaudet, A. L. (2000) · Virology · doi:10.1006/viro.2000.0515 · Cited by 43
Geest, B. D., Linthout, S. V., Lox, M., Collen, D., & Holvoet, P. (2000) · Human Gene Therapy · doi:10.1089/10430340050016193 · Cited by 43
Jiang, Z., Reay, D. P., Kreppel, F., Gambotto, A. A., Feingold, E., Kochanek, S., McCarthy, S. A., & Clemens, P. R. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0331 · Cited by 41
Ostapchuk, P., & Hearing, P. (2001) · Journal of Virology · doi:10.1128/jvi.75.1.45-51.2001 · Cited by 37
Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle
Löser, P., Hillgenberg, M., Arnold, W., Both, G. W., & Hofmann, C. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301260 · Cited by 32
Adenoviral Vectors Do Not Induce, Inhibit, or Potentiate Human Platelet Aggregation
Eggerman, T. L., Mondoro, T. H., Lozier, J. N., & Vostal, J. G. (2002) · Human Gene Therapy · doi:10.1089/10430340152712674 · Cited by 31
Budesonide Enhances Repeated Gene Transfer and Expression in the Lung with Adenoviral Vectors
Kolb, M. R. J., Inman, M. D., Margetts, P. J., Galt, T., & Gauldie, J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.5.2008066 · Cited by 29
Ziller, C., Stoeckel, F., Boon, L., & Haegel, H. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301684 · Cited by 20
Cited by
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Feng, L., Yang, X., Shi, X., Tan, X., Peng, R., Wang, J., & Liu, Z. (2013) · Small · doi:10.1002/smll.201202538 · Cited by 414
Lau, C.-H., & Suh, Y. (2017) · F1000Research · doi:10.12688/f1000research.11243.1 · Cited by 161
Advances in Gene Delivery Systems
Kamimura, K., Suda, T., Zhang, G., & Liu, D. (2011) · Pharmaceutical Medicine · doi:10.1007/bf03256872 · Cited by 124
Genetic Modification of the Lung Directed Toward Treatment of Human Disease
Sondhi, D., Stiles, K. M., De, B. P., & Crystal, R. G. (2017) · Human Gene Therapy · doi:10.1089/hum.2016.152 · Cited by 36
Metadata
- Authors
- St George, J. A.
- Venue
- Gene Therapy
- Published
- 2003-06-30
- Volume
- 10
- Issue
- 14
- Pages
- 1135-1141
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2046306990
- Cited by
- 294
- References
- 56
- FWCI
- 21.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.